申请人:NOVABIOTICS LTD
公开号:WO2021240145A1
公开(公告)日:2021-12-02
The invention relates to the use of compounds, and compositions comprising such compounds, for treating viral infection. More specifically, the compounds for use in the invention are comprised of structural formula (1), or a pharmaceutically acceptable salt thereof. The invention also relates to the compounds for use in treating hyperinflammation.